Literature DB >> 21735212

Relative reactivity of HIV-1 polyclonal plasma antibodies directed to V3 and MPER regions suggests immunodominance of V3 over MPER and dependence of high anti-V3 antibody titers on virus persistence.

Raiees Andrabi1, Alok K Choudhary, Manju Bala, Rajesh Kalra, S S Prakash, R M Pandey, Kalpana Luthra.   

Abstract

Antibodies to two crucial regions, the third variable loop (V3) of gp120 and the membrane-proximal external region (MPER) of gp41 are important for HIV-1 neutralization. We here evaluated the relative binding of polyclonal plasma antibodies from 99 HIV-1-infected individuals from India to the consensus-C V3 and MPER peptides and observed immunodominance of V3 over MPER (p < 0.0001). We further examined the V3- and MPER-specific antibody correlates with clinical parameters. Our results revealed that anti-V3 antibody titers are significantly lower in patients on ART compared to drug-naive individuals (p < 0.0001), most likely due to a decrease in plasma viral load, irrespective of their CD4 counts and total IgG. No such association was observed for MPER, with a similar trend in four follow-up patients. These findings strongly suggest that high titers of V3-specific antibodies are dependent on persistence of virus in circulation, while antibodies to MPER are probably not.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735212     DOI: 10.1007/s00705-011-1053-5

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

1.  Viral Characteristics Associated with Maintenance of Elite Neutralizing Activity in Chronically HIV-1 Clade C-Infected Monozygotic Pediatric Twins.

Authors:  Nitesh Mishra; Muzamil Ashraf Makhdoomi; Shaifali Sharma; Sanjeev Kumar; Ayushman Dobhal; Deepshikha Kumar; Himanshi Chawla; Ravinder Singh; Uma Kanga; Bimal Kumar Das; Rakesh Lodha; Sushil K Kabra; Kalpana Luthra
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

2.  Envelope diversity, characteristics of V3 region and predicted co-receptor usage of human immunodeficiency viruses infecting north Indians.

Authors:  Raiees Andrabi; Rajesh Kumar; Manju Bala; Ambili Nair; Prakash Ss; Vandana Kushwaha; Kalpana Luthra
Journal:  J Microbiol       Date:  2012-11-04       Impact factor: 3.422

3.  Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors.

Authors:  Raiees Andrabi; Rajesh Kumar; Manju Bala; Ambili Nair; Ashutosh Biswas; Naveet Wig; Pratik Kumar; Rahul Pal; Subrata Sinha; Kalpana Luthra
Journal:  Virol J       Date:  2012-09-12       Impact factor: 4.099

4.  Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India.

Authors:  Raiees Andrabi; Manju Bala; Rajesh Kumar; Naveet Wig; Anjali Hazarika; Kalpana Luthra
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

5.  A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C.

Authors:  Rajesh Kumar; Raiees Andrabi; Ashutosh Tiwari; Somi Sankaran Prakash; Naveet Wig; Durgashree Dutta; Anurag Sankhyan; Lubina Khan; Subrata Sinha; Kalpana Luthra
Journal:  BMC Biotechnol       Date:  2012-11-15       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.